• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪性肝病的营养与遗传学:完美的二联体。

Nutrition and Genetics in NAFLD: The Perfect Binomium.

机构信息

General Medicine and Metabolic Diseases, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Pad. Granelli, via F Sforza 35, 20122 Milan, Italy.

Department of Pathophysiology and Transplantation, Università degli Studi di Milano, 20122 Milano, Italy.

出版信息

Int J Mol Sci. 2020 Apr 23;21(8):2986. doi: 10.3390/ijms21082986.

DOI:10.3390/ijms21082986
PMID:32340286
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7215858/
Abstract

Nonalcoholic fatty liver disease (NAFLD) represents a global healthcare burden since it is epidemiologically related to obesity, type 2 diabetes (T2D) and Metabolic Syndrome (MetS). It embraces a wide spectrum of hepatic injuries, which include simple steatosis, nonalcoholic steatohepatitis (NASH), fibrosis, cirrhosis and hepatocellular carcinoma (HCC). The susceptibility to develop NAFLD is highly variable and it is influenced by several cues including environmental (i.e., dietary habits and physical activity) and inherited (i.e., genetic/epigenetic) risk factors. Nonetheless, even intestinal microbiota and its by-products play a crucial role in NAFLD pathophysiology. The interaction of dietary exposure with the genome is referred to as which encompasses both and It is focused on revealing the biological mechanisms that entail both the acute and persistent genome-nutrient interactions that influence health and it may represent a promising field of study to improve both clinical and health nutrition practices. Thus, the premise of this review is to discuss the relevance of personalized nutritional advices as a novel therapeutic approach in NAFLD tailored management.

摘要

非酒精性脂肪性肝病(NAFLD)是一种全球性的医疗保健负担,因为它与肥胖、2 型糖尿病(T2D)和代谢综合征(MetS)在流行病学上有关。它包含广泛的肝损伤,包括单纯性脂肪变性、非酒精性脂肪性肝炎(NASH)、纤维化、肝硬化和肝细胞癌(HCC)。发生 NAFLD 的易感性差异很大,受到多种因素的影响,包括环境因素(如饮食习惯和体力活动)和遗传因素(如遗传/表观遗传)。尽管如此,即使是肠道微生物群及其产物也在 NAFLD 发病机制中发挥着关键作用。饮食暴露与基因组的相互作用被称为“营养基因组学”,它既包括“基因组-营养”相互作用,也包括“环境-基因组”相互作用。它专注于揭示涉及急性和持续的基因组-营养相互作用的生物学机制,这些相互作用影响健康,可能是改善临床和健康营养实践的一个有前途的研究领域。因此,本文的前提是讨论个性化营养建议作为一种针对 NAFLD 量身定制的新型治疗方法的相关性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/7215858/c7fc38359180/ijms-21-02986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/7215858/c7fc38359180/ijms-21-02986-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6b95/7215858/c7fc38359180/ijms-21-02986-g001.jpg

相似文献

1
Nutrition and Genetics in NAFLD: The Perfect Binomium.非酒精性脂肪性肝病的营养与遗传学:完美的二联体。
Int J Mol Sci. 2020 Apr 23;21(8):2986. doi: 10.3390/ijms21082986.
2
Nutrigenomics analysis reveals that copper deficiency and dietary sucrose up-regulate inflammation, fibrosis and lipogenic pathways in a mature rat model of nonalcoholic fatty liver disease.营养基因组学分析表明,在非酒精性脂肪性肝病的成熟大鼠模型中,铜缺乏和膳食蔗糖会上调炎症、纤维化和脂肪生成途径。
J Nutr Biochem. 2015 Oct;26(10):996-1006. doi: 10.1016/j.jnutbio.2015.04.009. Epub 2015 May 15.
3
Molecular Mechanisms: Connections between Nonalcoholic Fatty Liver Disease, Steatohepatitis and Hepatocellular Carcinoma.分子机制:非酒精性脂肪性肝病、脂肪性肝炎和肝细胞癌之间的联系。
Int J Mol Sci. 2020 Feb 23;21(4):1525. doi: 10.3390/ijms21041525.
4
A Nutrigenomic Approach to Non-Alcoholic Fatty Liver Disease.一种针对非酒精性脂肪性肝病的营养基因组学方法。
Int J Mol Sci. 2017 Jul 16;18(7):1534. doi: 10.3390/ijms18071534.
5
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的临床流行病学和疾病负担。
World J Gastroenterol. 2017 Dec 21;23(47):8263-8276. doi: 10.3748/wjg.v23.i47.8263.
6
Nutrigenetic Interactions Might Modulate the Antioxidant and Anti-Inflammatory Status in Mastiha-Supplemented Patients With NAFLD.营养遗传学相互作用可能调节富含乳香的 NAFLD 患者的抗氧化和抗炎状态。
Front Immunol. 2021 May 7;12:683028. doi: 10.3389/fimmu.2021.683028. eCollection 2021.
7
The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies.益生菌在非酒精性脂肪性肝病中的作用:治疗策略的新视角。
Nutrients. 2019 Nov 4;11(11):2642. doi: 10.3390/nu11112642.
8
Genetic and epigenetic mechanisms of NASH.NASH 的遗传和表观遗传机制。
Hepatol Int. 2016 May;10(3):394-406. doi: 10.1007/s12072-015-9689-y. Epub 2015 Dec 18.
9
[Pathogenesis of non-alcoholic fatty liver disease].[非酒精性脂肪性肝病的发病机制]
Presse Med. 2019 Dec;48(12):1468-1483. doi: 10.1016/j.lpm.2019.09.051. Epub 2019 Nov 22.
10
Flame Retardants-Mediated Interferon Signaling in the Pathogenesis of Nonalcoholic Fatty Liver Disease.阻燃剂介导的非酒精性脂肪性肝病发病机制中的干扰素信号。
Int J Mol Sci. 2021 Apr 20;22(8):4282. doi: 10.3390/ijms22084282.

引用本文的文献

1
MASLD Under the Microscope: How microRNAs and Microbiota Shape Hepatic Metabolic Disease Progression.显微镜下的代谢相关脂肪性肝病:微小RNA和微生物群如何影响肝脏代谢性疾病进展
Int J Mol Sci. 2025 Sep 4;26(17):8633. doi: 10.3390/ijms26178633.
2
Intestinal Depletion of TM6SF2 Exacerbates High-fat Diet-induced Metabolic Dysfunction-associated Steatotic Liver Disease through the Gut-liver Axis.肠道中TM6SF2的缺失通过肠-肝轴加剧高脂饮食诱导的代谢功能障碍相关脂肪性肝病。
J Clin Transl Hepatol. 2025 Jun 28;13(6):443-455. doi: 10.14218/JCTH.2024.00407. Epub 2025 Mar 12.
3
The therapeutic mechanisms of quercetin on inflammatory diseases: an update.

本文引用的文献

1
Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes.高胰岛素血症下调 Mboat7 诱导肝细胞脂肪堆积。
EBioMedicine. 2020 Feb;52:102658. doi: 10.1016/j.ebiom.2020.102658. Epub 2020 Feb 12.
2
Association of Monogenic vs Polygenic Hypercholesterolemia With Risk of Atherosclerotic Cardiovascular Disease.单基因与多基因高胆固醇血症与动脉粥样硬化性心血管疾病风险的关联。
JAMA Cardiol. 2020 Apr 1;5(4):390-399. doi: 10.1001/jamacardio.2019.5954.
3
Green Tea Prevents NAFLD by Modulation of miR-34a and miR-194 Expression in a High-Fat Diet Mouse Model.
槲皮素对炎症性疾病的治疗机制:最新进展
Inflammopharmacology. 2025 May 31. doi: 10.1007/s10787-025-01795-x.
4
Managing Nonalcoholic Fatty Liver Disease Through Structured Lifestyle Modification Interventions.通过结构化生活方式改变干预措施管理非酒精性脂肪性肝病
Am J Lifestyle Med. 2025 May 26:15598276251346717. doi: 10.1177/15598276251346717.
5
Mitochondrial Dysfunction as a Pathogenesis and Therapeutic Strategy for Metabolic-Dysfunction-Associated Steatotic Liver Disease.线粒体功能障碍作为代谢功能障碍相关脂肪性肝病的发病机制及治疗策略
Int J Mol Sci. 2025 Apr 30;26(9):4256. doi: 10.3390/ijms26094256.
6
Identification of pyroptosis-associated gene to predict fibrosis and reveal immune characterization in non-alcoholic fatty liver disease.鉴定焦亡相关基因以预测非酒精性脂肪性肝病中的纤维化并揭示免疫特征
Sci Rep. 2025 Apr 29;15(1):14944. doi: 10.1038/s41598-025-96158-5.
7
The Impact of Dietary Sugars and Saturated Fats on Body and Liver Fat in a Healthcare Worker Population.饮食中的糖类和饱和脂肪对医护人员群体身体脂肪和肝脏脂肪的影响
Nutrients. 2025 Apr 11;17(8):1328. doi: 10.3390/nu17081328.
8
The Role of the Gut-Biliary-Liver Axis in Primary Hepatobiliary Liver Cancers: From Molecular Insights to Clinical Applications.肠道-胆管-肝脏轴在原发性肝胆管癌中的作用:从分子洞察到临床应用
J Pers Med. 2025 Mar 24;15(4):124. doi: 10.3390/jpm15040124.
9
A cross-sectional study of risk factors associated with sarcopenia in patients with metabolic dysfunction-associated steatotic liver disease.一项关于代谢功能障碍相关脂肪性肝病患者肌肉减少症相关危险因素的横断面研究。
Front Med (Lausanne). 2025 Feb 18;12:1488068. doi: 10.3389/fmed.2025.1488068. eCollection 2025.
10
Association between NAFLD and liver fibrosis with nutritional risk index based on the NHANES 2017-2018.基于2017 - 2018年美国国家健康与营养检查调查(NHANES)的营养风险指数评估非酒精性脂肪性肝病(NAFLD)与肝纤维化之间的关联。
Lipids Health Dis. 2025 Jan 7;24(1):6. doi: 10.1186/s12944-024-02427-z.
绿茶通过调节高脂肪饮食诱导的 NAFLD 模型中 miR-34a 和 miR-194 的表达来预防非酒精性脂肪性肝病。
Oxid Med Cell Longev. 2019 Dec 4;2019:4168380. doi: 10.1155/2019/4168380. eCollection 2019.
4
The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies.益生菌在非酒精性脂肪性肝病中的作用:治疗策略的新视角。
Nutrients. 2019 Nov 4;11(11):2642. doi: 10.3390/nu11112642.
5
mir-101-3p Downregulation Promotes Fibrogenesis by Facilitating Hepatic Stellate Cell Transdifferentiation During Insulin Resistance.miR-101-3p 下调通过促进肝星状细胞转分化促进胰岛素抵抗中的肝纤维化。
Nutrients. 2019 Oct 29;11(11):2597. doi: 10.3390/nu11112597.
6
β-Klotho gene variation is associated with liver damage in children with NAFLD.β-klotho 基因变异与非酒精性脂肪性肝病患儿的肝损伤有关。
J Hepatol. 2020 Mar;72(3):411-419. doi: 10.1016/j.jhep.2019.10.011. Epub 2019 Oct 23.
7
Alcohol or Gut Microbiota: Who Is the Guilty?酒精还是肠道微生物群:谁是罪魁祸首?
Int J Mol Sci. 2019 Sep 14;20(18):4568. doi: 10.3390/ijms20184568.
8
Oral α-lipoic acid supplementation in patients with non-alcoholic fatty liver disease: effects on adipokines and liver histology features.口服 α-硫辛酸补充剂治疗非酒精性脂肪性肝病患者:对脂联素和肝脏组织学特征的影响。
Food Funct. 2019 Aug 1;10(8):4941-4952. doi: 10.1039/c9fo00449a. Epub 2019 Jul 25.
9
Gut Microbiome: Profound Implications for Diet and Disease.肠道微生物组:饮食与疾病的深远影响。
Nutrients. 2019 Jul 16;11(7):1613. doi: 10.3390/nu11071613.
10
miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease.miR-122 通过靶向 Sirt1 抑制 LKB1/AMPK 通路促进非酒精性脂肪性肝病中的肝脂肪生成。
Mol Med. 2019 Jun 13;25(1):26. doi: 10.1186/s10020-019-0085-2.